Alight names siobhan nolan mangini to board of directors

Lincolnshire, ill.--(business wire)--alight, inc. (nyse: alit), a leading cloud-based human capital technology and services provider, today announced that it has named siobhan nolan mangini to its board of directors, effective january 1, 2024. ms. nolan mangini brings over two decades of healthcare experience to alight, most recently serving as president and cfo of ngm biopharmaceuticals, inc., a clinical-stage biopharmaceutical company specializing in therapies for immuno-oncology, cardiometab.
ALIT Ratings Summary
ALIT Quant Ranking